• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SMYD3和基质金属蛋白酶-9的过表达与胃癌患者的不良预后相关。

Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.

作者信息

Liu Yong, Liu Honggen, Luo Xuegang, Deng Jingyu, Pan Yuan, Liang Han

机构信息

Department of Gastric Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.

出版信息

Tumour Biol. 2015 Jun;36(6):4377-86. doi: 10.1007/s13277-015-3077-z. Epub 2015 Jan 28.

DOI:10.1007/s13277-015-3077-z
PMID:25627005
Abstract

SET and MYND domain-containing protein 3 (SMYD3) plays a key role in the progression of human cancer. Matrix metalloproteinase (MMP)-9 is being related to tumor progression. It has been reported that SMYD3 and MMP-9 are overexpressed in human cancers. However, the exact roles of SMYD3 and MMP-9 in the metastasis and prognosis of gastric cancer (GC) remain unclear. The expressions of SMYD3 and MMP-9 were detected by semiquantitative reverse transcription polymerase chain reaction and Western blotting in gastric cancer and adjacent nontumor tissues. In addition, SMYD3 and MMP-9 expressions were analyzed by immunohistochemistry in formalin-fixed samples from 186 gastric cancer patients. The messenger RNA (mRNA) and protein expression levels of SMYD3 and MMP-9 in gastric cancer tissues were both significantly higher than those in adjacent nontumor tissues. In addition, the expression of SMYD3 was correlated with size of primary tumor and lymph node metastasis, while size of primary tumor and serosal invasion were identified as the independently relative factors of MMP-9 expression in GC tissues. SMYD3 expression and MMP-9 expression in GC tissues were significantly and positively correlated. Multivariate analysis results demonstrated that degree of differentiation, lymph node metastasis, TNM stage, SMYD3 expression, and MMP-9 expression were the independent prognostic indicators of gastric cancer. SMYD3 and MMP-9 may play important roles in tumor invasion, metastasis, and prognosis and could work as promising targets for prognostic prediction in gastric cancer.

摘要

含SET和MYND结构域蛋白3(SMYD3)在人类癌症进展中起关键作用。基质金属蛋白酶(MMP)-9与肿瘤进展有关。据报道,SMYD3和MMP-9在人类癌症中过表达。然而,SMYD3和MMP-9在胃癌(GC)转移和预后中的确切作用仍不清楚。采用半定量逆转录聚合酶链反应和蛋白质印迹法检测胃癌组织及癌旁非肿瘤组织中SMYD3和MMP-9的表达。此外,通过免疫组织化学分析186例胃癌患者福尔马林固定样本中的SMYD3和MMP-9表达。胃癌组织中SMYD3和MMP-9的信使核糖核酸(mRNA)和蛋白表达水平均显著高于癌旁非肿瘤组织。此外,SMYD3的表达与原发肿瘤大小和淋巴结转移相关,而原发肿瘤大小和浆膜侵犯被确定为GC组织中MMP-9表达的独立相关因素。GC组织中SMYD3表达与MMP-9表达显著正相关。多因素分析结果显示,分化程度、淋巴结转移、TNM分期、SMYD3表达和MMP-9表达是胃癌的独立预后指标。SMYD3和MMP-9可能在肿瘤侵袭、转移和预后中起重要作用,并且可能成为胃癌预后预测的有前景的靶点。

相似文献

1
Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.SMYD3和基质金属蛋白酶-9的过表达与胃癌患者的不良预后相关。
Tumour Biol. 2015 Jun;36(6):4377-86. doi: 10.1007/s13277-015-3077-z. Epub 2015 Jan 28.
2
SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.SMYD3过表达是胃癌生物学行为和预后的一个危险因素。
Tumour Biol. 2015 Apr;36(4):2685-94. doi: 10.1007/s13277-014-2891-z. Epub 2014 Dec 4.
3
Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.SMYD3的过表达与胃癌中STAT3激活增加有关。
Med Oncol. 2015 Jan;32(1):404. doi: 10.1007/s12032-014-0404-y. Epub 2014 Dec 4.
4
Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer.SET 和 MYND 结构域蛋白 3 的水平升高与胃癌中转化生长因子-β1 的过表达相关。
J Am Coll Surg. 2015 Aug;221(2):579-90. doi: 10.1016/j.jamcollsurg.2015.02.023. Epub 2015 Mar 4.
5
Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer.SMYD3 的过表达促进胰腺癌的增殖、迁移和侵袭。
Dig Dis Sci. 2020 Feb;65(2):489-499. doi: 10.1007/s10620-019-05797-y. Epub 2019 Aug 22.
6
Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.Twist和基质金属蛋白酶-9的过表达与胃癌转移及预后的关系
Asian Pac J Cancer Prev. 2013;14(9):5055-60. doi: 10.7314/apjcp.2013.14.9.5055.
7
[Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].基质金属蛋白酶与金属蛋白酶组织抑制剂表达失衡与胃癌侵袭和转移的关系
Ai Zheng. 2002 Mar;21(3):305-10.
8
SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.SMYD3 通过表观遗传地上调金属蛋白酶 MMP-9 促进癌症侵袭。
Cancer Res. 2012 Feb 1;72(3):810-20. doi: 10.1158/0008-5472.CAN-11-1052. Epub 2011 Dec 22.
9
MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.基质金属蛋白酶-2(MMP-2)与基质金属蛋白酶-9(MMP-9)的过表达与早期胃癌的淋巴结转移及不良预后相关。
Tumour Biol. 2017 Jun;39(6):1010428317700411. doi: 10.1177/1010428317700411.
10
Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.脊椎蛋白-2表达升高与胃癌的进展及预后相关。
Oncotarget. 2017 Feb 7;8(6):10416-10424. doi: 10.18632/oncotarget.14423.

引用本文的文献

1
The Percentage of Neutrophils is Independently Associated with Blood-Brain Barrier(BBB) Disruption in Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD).在髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)中,中性粒细胞百分比与血脑屏障(BBB)破坏独立相关。
J Inflamm Res. 2025 Feb 25;18:2823-2836. doi: 10.2147/JIR.S501150. eCollection 2025.
2
SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay.SP-1激活的LINC01016过表达通过抑制EIF4A3介导的MMP9 mRNA衰变促进胃癌侵袭和转移。
Cell Death Dis. 2025 Jan 29;16(1):54. doi: 10.1038/s41419-024-07250-z.
3

本文引用的文献

1
SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.SMYD3过表达是胃癌生物学行为和预后的一个危险因素。
Tumour Biol. 2015 Apr;36(4):2685-94. doi: 10.1007/s13277-014-2891-z. Epub 2014 Dec 4.
2
Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.SMYD3的过表达与胃癌中STAT3激活增加有关。
Med Oncol. 2015 Jan;32(1):404. doi: 10.1007/s12032-014-0404-y. Epub 2014 Dec 4.
3
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation.
A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter.
一种通过降低Rac1启动子的H3K4三甲基化靶向SMYD3治疗肝细胞癌的新型小分子ZYZ384。
MedComm (2020). 2024 Sep 15;5(10):e711. doi: 10.1002/mco2.711. eCollection 2024 Oct.
4
Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives.胃肠道癌中的表观遗传重编程:生物学与转化医学视角
MedComm (2020). 2024 Aug 24;5(9):e670. doi: 10.1002/mco2.670. eCollection 2024 Sep.
5
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance.新型 SMYD3 抑制剂 EM127 可破坏化疗引起的 DNA 损伤的 DNA 修复反应并逆转肿瘤的化疗耐药性。
J Exp Clin Cancer Res. 2024 May 30;43(1):151. doi: 10.1186/s13046-024-03078-9.
6
Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways.杀伤细胞凝集素样受体 G2 通过双重激活 ERK1/2 和 JAK/STAT 通路促进胃癌细胞的侵袭表型。
Gastric Cancer. 2024 May;27(3):506-518. doi: 10.1007/s10120-024-01480-y. Epub 2024 Feb 22.
7
Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities.组蛋白和DNA甲基化作为胃癌中DNA损伤修复的表观遗传调节因子及新出现的治疗机会
Cancers (Basel). 2023 Oct 13;15(20):4976. doi: 10.3390/cancers15204976.
8
Identification, Antioxidant Capacity, and Matrix Metallopeptidase 9 (MMP-9) In Silico Inhibition of Haloarchaeal Carotenoids from sp. and .来自[具体物种1]和[具体物种2]的嗜盐古菌类胡萝卜素的鉴定、抗氧化能力及基质金属蛋白酶9(MMP-9)的计算机模拟抑制
Microorganisms. 2023 Sep 19;11(9):2344. doi: 10.3390/microorganisms11092344.
9
Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma.综合分析鉴定 CACNG3 为胶质瘤患者的预后生物标志物。
BMC Cancer. 2023 Sep 11;23(1):846. doi: 10.1186/s12885-023-10896-1.
10
Characterization of the Gene and Its Association with Resistance Traits in (Linnaeus, 1758).家蚕(Linnaeus,1758)基因特征及其与抗性性状的关联分析。
Genes (Basel). 2023 Feb 13;14(2):475. doi: 10.3390/genes14020475.
Smyd3 调节癌细胞表型,并催化组蛋白 H4 赖氨酸 5 甲基化。
Epigenetics. 2012 Apr;7(4):340-3. doi: 10.4161/epi.19506. Epub 2012 Apr 1.
4
SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.SMYD3 通过表观遗传地上调金属蛋白酶 MMP-9 促进癌症侵袭。
Cancer Res. 2012 Feb 1;72(3):810-20. doi: 10.1158/0008-5472.CAN-11-1052. Epub 2011 Dec 22.
5
Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.基质金属蛋白酶-9 与胃癌患者的无病生存率和总生存率相关。
Int J Cancer. 2011 Aug 15;129(4):887-95. doi: 10.1002/ijc.25734. Epub 2010 Dec 8.
6
Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis.基质金属蛋白酶 2 和 9 在人胃癌和浅表性胃炎中的表达。
World J Gastroenterol. 2010 Mar 28;16(12):1500-5. doi: 10.3748/wjg.v16.i12.1500.
7
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.基质金属蛋白酶作为人类癌症中的新型生物标志物和潜在治疗靶点。
J Clin Oncol. 2009 Nov 1;27(31):5287-97. doi: 10.1200/JCO.2009.23.5556. Epub 2009 Sep 8.
8
Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription.雌激素受体介导的转录对组蛋白甲基转移酶SMYD3的需求。
J Biol Chem. 2009 Jul 24;284(30):19867-77. doi: 10.1074/jbc.M109.021485. Epub 2009 Jun 9.
9
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
10
Effects of SMYD3 overexpression on transformation, serum dependence, and apoptosis sensitivity in NIH3T3 cells.SMYD3过表达对NIH3T3细胞转化、血清依赖性及凋亡敏感性的影响。
IUBMB Life. 2009 Jun;61(6):679-84. doi: 10.1002/iub.216.